Wednesday Dec 4
Laboratoire Cerba launches noninvasive prenatal test in multiple countries
Sequenom, Inc. , a life sciences company providing innovative testing and genetic analysis solutions, announced that Laboratoire Cerba has launched its validated noninvasive prenatal test to health care providers and their patients in Africa.
Wednesday Dec 4
San Diego Source
Sequenom launches noninvasive prenatal test in France
San Diego-based Sequenom Inc. announced Wednesday that Laboratoire Cerba has launched its validated noninvasive prenatal test to health care providers and their patients in France, Belgium, Luxembourg and portions of the Middle East and Africa.
Sequenom Inc. Announces Participation At The Oppenheimer 24th Annual Healthcare Conference
The presentation is expected to last approximately 30 minutes and will be an audio webcast live through the "Invest" section of the Sequenom Web site at www.sequenom.com .
Sequenom: Is The Bottom In The Rearview Mirror?
Five months ago, I wrote two articles describing the market for Noninvasive Prenatal Diagnostics.
Worth Watching Stocks: MannKind Corporation (NASDAQ:MNKD), Sequenom,...
Jet Life Penny Stocks provides investors with the some of the most Awesome Penny Stock alerts on a regular basis.
Small-Cap Standout: Sequenom, Inc.
Small-cap stocks -- those that typically hold a market valuation of roughly $300 million to $2 billion -- often allow investors the opportunity to trade at a lower cost.
Sequenom: Current Status
Shares of Sequenom bounced back following the announcement of its Q3 financial results.
Salix price target raised to $106 from $84 at Piper Jaffray
Salix price target raised to $106 from $84 at Piper Jaffray Piper Jaffray raised its price target for Salix Pharmaceuticals to $106 citing the acquisition of Santarus and the company's strong base business.
Patent Claims for Prenatal Diagnostic Method Invalidated as Ineligible Subject Matter
The U.S. District Court for the Northern District of California found Sequenom's patent claims on a prenatal diagnostic method to be invalid and not infringed by Arisoa Diagnostic's Harmony Test product, because the asserted claims were directed at patent ineligible subject matter.
Stocks on the Run - Sequenom, Inc. (NASDAQ:SQNM), Office Depot Inc...
High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis.